Oracle shares closed Friday at €112.60, capping a week that saw the stock climb 11.31 percent. The bounce marks a recovery from the 52-week low of €100.76, a level touched as recently as July 28. But strip away the weekly gain and the picture turns sobering: the stock remains down 32.25 percent year-to-date and sits nearly 60 percent below its September 2025 record high.
The real action, however, isn’t in the equity at all. It’s in the credit market, where Oracle’s five-year credit default swaps have climbed to multi-year highs. Investors are demanding a meaningfully larger premium to insure against an Oracle default — and that shift has turned the company into something of a canary for the entire AI infrastructure trade.
The Conversion Race
At the heart of Oracle’s investment case is a single race: can the company convert its record backlog into cash faster than new financing obligations pile up?
The numbers are staggering on both sides. Remaining performance obligations — contractually secured future revenue — hit $638 billion at quarter-end, up 363 percent year-over-year. Operating cash flow rose 54 percent to $32.0 billion in fiscal 2026. Yet free cash flow went negative, landing at minus $23.7 billion.
That gap forces Oracle to lean heavily on external capital markets to keep funding its infrastructure buildout. The market’s indecision is visible in the technicals: an RSI of 43.2 and annualized 30-day volatility above 53 percent suggest investors haven’t settled on which narrative wins.
The Bull Case: Prepaid Contracts and Protected Margins
Optimists point to the structure of demand, not just its size. CEO Clay Magouyrk reported $67 billion in new AI infrastructure contracts in the quarter alone, with the majority structured as either “bring-your-own-hardware” or prepaid deals — arrangements that protect margins and reduce Oracle’s own capital requirements.
Management expects 12 percent of the backlog to convert to revenue over the next twelve months, or roughly $76.6 billion — comfortably more than the $67 billion Oracle generated in all of fiscal 2026. The company’s fiscal 2027 guidance calls for $90 billion in revenue, a 34 percent increase on a currency-adjusted basis. First-quarter growth is projected between 27 and 29 percent, with the cloud business expanding 58 to 64 percent.
If that pace holds, the average analyst price target of €216.25 — implying upside of roughly 92 percent from Friday’s close — becomes the reference point for bulls. Some Wall Street voices already argue the sell-off overshot what the RPO growth justifies.
The Bear Case: A Balance Sheet Under Pressure
The risk side is equally concrete. S&P Global Ratings downgraded Oracle from BBB to BBB- on July 9, leaving the company just one notch above junk status. The reason: the enormous cost of the AI infrastructure buildout. The market increasingly treats Oracle’s AI opportunity as a balance-sheet risk.
Should investors sell immediately? Or is it worth buying Oracle?
The financing math is unforgiving. Oracle took on $43 billion in new debt in fiscal 2026, plus $5 billion in equity. For 2027, the company plans another $40 billion in combined financing — including an announced $20 billion equity program that can be placed into the market at any time. That facility creates a self-reinforcing dynamic: every stock recovery invites fresh dilution.
One research house estimates Oracle could need up to $500 billion in capital by 2030 to build out its AI cloud infrastructure, with internally generated cash flow covering only about 20 percent of that. The company has already cut roughly 21,000 jobs — about 13 percent of its workforce — as part of the AI restructuring.
Execution risk compounds the financing concerns. New Mexico regulators rejected for a second time the gas pipeline permit for Project Jupiter, the massive AI data center developed jointly with OpenAI, citing environmental concerns and insufficient benefit to the state. There’s also concentration risk: a large portion of the backlog rests on a single customer, OpenAI, whose financial stability lies outside Oracle’s control.
A Deliberate Financing Plan — For Now
Oracle has made clear it intends to defend its investment-grade rating while funding the cloud expansion. The financing plan for calendar 2026 targets gross proceeds between $45 and $50 billion, split between debt and equity. Crucially, the company plans a single, one-time investment-grade bond issuance in early 2026 to cover the second half of that funding need — no further bond offerings are planned for the calendar year.
That commitment matters for interpreting the current credit tension. The market is repricing an existing risk, not signaling that Oracle needs unplanned fresh capital outside its stated framework. Whether that distinction holds will be tested less by the next partnership announcement than by the next move from bondholders.
What to Watch
The next hard data point arrives mid-September, when Oracle reports fiscal first-quarter results. Investors will also be watching whether the company honors its pledge to take on no additional debt during calendar 2026. Any deviation would be an immediate signal of which side — financing need or growth story — currently has the upper hand.
The weekly rally of 11.31 percent and a not-yet-overbought RSI could support the case for a bottom forming. But with the stock trading 21.05 percent below its 50-day average of €142.63 and 27.64 percent below its 200-day average of €155.61, one week of relief buying doesn’t close that gap. The volatility reading of 53.56 percent annualized says the market continues to price substantial risk in both directions.
For now, Oracle is the name through which the credit market is rehearsing a question every hyperscaler will eventually face: how much debt can the AI buildout absorb before lenders start to flinch?
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from August 1 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 1.
Oracle: Buy or sell? Read more here...









